Syngene appoints Sanjeev Sukumaran as CHRO.
Mumbai, India, 7th June, 2021: Syngene International, an integrated research, development and manufacturing services company, has appointed Mr. Sanjeev Sukumaran as Chief Human Resource Officer (CHRO) with effect from 1st June, 2021. Sanjeev succeeded Vinita Shrivastava.
As the CHRO, Sanjeev will be responsible for building on Syngene’s people-centric organizational development priorities including HR strategy development, driving organisational matrices, talent management and sustaining an inclusive work culture. His focus will be on attracting and nurturing diverse scientific talent and promote innovation, excellence and a passion to making a difference in the lives of millions by putting science to work.
Commenting on the appointment of Sanjeev, Jonathan Hunt, MD and CEO, Syngene International Ltd. said, “As we continue on our journey to create a world-class innovation-focused organization, I am confident that Sanjeev, with his diverse experience, will be able to implement the right systems, processes and initiatives to create an environment that attracts, retains and develops the best talent.”
Sanjeev said, “I am excited to take on this role and drive the people-initiatives at Syngene. Over the last few years, Syngene has evolved to be a global scale scientific solutions provider to multiple industries. Attracting the best talent and giving them the right environment to drive innovation is critical to the organization’s vision.”
Sanjeev joined Syngene in October 2017 as the Chief of Staff and was responsible for driving key strategic initiatives across the organisation. A Mechanical Engineer with a management degree from the Indian Institute of Management (IIM), Kozhikode and an Executive Leadership Program from INSEAD, Singapore, Sanjeev has nearly 25 years of experience in the areas of strategic management, business advisory, and people management. Prior to joining Syngene, he has worked in a range of sectors including healthcare, life sciences, financial services, software and IT, FMCG, big data, supply chain management, e-commerce and shipping.
About Syngene
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022), is an integrated research, development and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors. Syngene's more than 4700 scientists offer both skills and the capacity to deliver great science, robust data management and IP security and quality manufacturing at speed, to improve time-to-market and lower the cost of innovation. With a combination of dedicated research facilities for Amgen, Baxter, Bristol-Myers Squibb and Herbalife, as well as 2 Mn sq. ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as well as multinationals including GSK and Merck KGaA.
For more details, visit www.syngeneintl.com
